4Kun LE.Acute Lymphoblastic Leukemia[J].Semin Radia Oncol,1997,7(3):185-194.
5Aumente D,Buelga DS,Lukas JC,et al.Population pharmacokinetics of high-dose methotrexate in children with acute lymphoblastic leukaemia[J].Clin Pharmacokinet,2006,45(12):1227-1238.
6Kagawa Y,Mukohara R,Hori H,et al.Fever as a risk factor causing delayed elimination of methotrexate in pediatric patient receiving high dose of cancer chemotherapy[J].Cancer Chemother Pharmacol,2004,54(1):34-38.
7Cohen IJ.Defining the appropriate dosage of folinic acid after high dose methotrexate for childhood acute lymphatic leukemia that will prevent neurotoxicity without rescuing malignant cells in the central nervous system[J].J Pediatr Hematol Oncol,2004,26(3):156163.
8Masson E,Reling MV,Synold TW,et al.Accumulation of methotrexate polyglutamates in lymphoblasts is a determinant of antileukemic effect in vivo:a rationale for high-dose methotrexate.J Clin Invest,1996,97:73-80.
9Miller AB,Hoogstraten B,Staquet M,et al.Reporting results of cancer treatment [WHO,1979].Cancer,1981,47(1):207-214.
